Cirrhosis electrocardiogram: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cirrhosis}}
{{Cirrhosis}}
{{CMG}}
{{CMG}} {{AE}} {{Cherry}}
 
==Overview==
==Overview==
In a few patients with [[cirrhosis]], circulating toxins may cause the [[The electrocardiogram|ECG]] to show prolongation of the [[QT interval]]. Low voltage complexes in the [[Electrocardiogram|precordial leads]] may also be noticed in [[Patient|patients]] due to [[Hypervolemia|fluid overload]].
==Electrocardiogram==
==Electrocardiogram==
Abnormalities of cardiac electrophysiology are noted in cirrhosis. The most common finding is QT interval prolongation.
Abnormalities of [[cardiac electrophysiology]] may be noted in [[cirrhosis]]. The most common finding is [[QT prolongation|QT interval prolongation]].
;QT interval prolongation
;QT interval prolongation <ref name="pmid22149582">{{cite journal |author=Bernardi M, Maggioli C, Dibra V, Zaccherini G |title=QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? |journal=[[Expert Review of Gastroenterology & Hepatology]] |volume=6 |issue=1 |pages=57–66 |year=2012 |pmid=22149582 |doi=10.1586/egh.11.86 |url=http://www.future-drugs.com/doi/abs/10.1586/egh.11.86?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed |accessdate=2012-09-06}}</ref>
* It is a sign of cirrhotic cardiomyopathy.
* It is a sign of [[Cirrhosis|cirrhotic]] [[cardiomyopathy]].
* It can be due to the circulating toxins in the blood stream.
* It may be due to the following:
* It may be due to drugs used in treatment of cirrhosis
** Circulating [[Toxin|toxins]] in the blood stream
* Stress due to bleed, shock or surgery(transplantation)
** [[:Category:Drugs|Drugs]]
** Stress due to [[hemorrhage]], [[shock]] or [[surgery]] ([[liver transplantation]])
 
;Attenuation of ECG voltage <ref name="pmid17344308">{{cite journal |author=Madias JE |title=Attenuation of ECG voltage in cirrhotic patients |journal=[[Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology]] |volume=9 |issue=3 |pages=175–81 |year=2007 |pmid=17344308 |doi=10.1093/europace/eul182 |url=http://europace.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17344308 |accessdate=2012-09-06}}</ref>
* Attenuation of ECG voltages is noticed mainly in patients who have [[ascites]] and peripheral [[edema]]
* This finding may be corrected by placing leads [[Anatomical terms of location|cranially]]<ref>http://europace.oxfordjournals.org/content/10/1/96.abstract</ref>
* [[Peripheral edema]] may be strongly correlated with this finding
* [[diuretics|Diuretic]] use in case of [[Pedal edema|peripheral edema]] leads to improvement in ECG findings
* [[paracentesis]] has no effect on [[The electrocardiogram|ECG]] findings<ref name="pmid17344308">{{cite journal |author=Madias JE |title=Attenuation of ECG voltage in cirrhotic patients |journal=[[Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology]] |volume=9 |issue=3 |pages=175–81 |year=2007 |month=March |pmid=17344308 |doi=10.1093/europace/eul182 |url=http://europace.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17344308 |accessdate=2012-09-06}}</ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Disease]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 10:30, 13 December 2017

Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Cirrhosis electrocardiogram On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cirrhosis electrocardiogram

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cirrhosis electrocardiogram

CDC on Cirrhosis electrocardiogram

Cirrhosis electrocardiogram in the news

Blogs on Cirrhosis electrocardiogram

Directions to Hospitals Treating Cirrhosis

Risk calculators and risk factors for Cirrhosis electrocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Overview

In a few patients with cirrhosis, circulating toxins may cause the ECG to show prolongation of the QT interval. Low voltage complexes in the precordial leads may also be noticed in patients due to fluid overload.

Electrocardiogram

Abnormalities of cardiac electrophysiology may be noted in cirrhosis. The most common finding is QT interval prolongation.

QT interval prolongation [1]
Attenuation of ECG voltage [2]

References

  1. Bernardi M, Maggioli C, Dibra V, Zaccherini G (2012). "QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?". Expert Review of Gastroenterology & Hepatology. 6 (1): 57–66. doi:10.1586/egh.11.86. PMID 22149582. Retrieved 2012-09-06.
  2. 2.0 2.1 Madias JE (2007). "Attenuation of ECG voltage in cirrhotic patients". Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 9 (3): 175–81. doi:10.1093/europace/eul182. PMID 17344308. Retrieved 2012-09-06.
  3. http://europace.oxfordjournals.org/content/10/1/96.abstract

Template:WH Template:WS